Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More – Xconomy
Xconomy |
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More
Xconomy Gene editing took an important step this week when a group of U.S. researchers used CRISPR-Cas9 technology to correct a genetic error in dozens of human embryos without complications. It's a significant achievement, but amidst the hype, it's worth … |
